BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GSK5533524 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of GSK5533524\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07438782-11217@assetmemo.bio
DTSTAMP:20261121T005736Z
DTSTART;VALUE=DATE:20290206
DTEND;VALUE=DATE:20290207
SUMMARY:GSK5533524: Phase 1 readout est. (NCT07438782)
DESCRIPTION:GSK5533524\, phase 1\, Advanced Solid Tumors.\nStudy: First Tim
 e in Human (FTIH) Study to Investigate the Safety and Preliminary Activity
  of GSK5533524 Alone or in Combination in Adult Participants With Advanced
  Solid Tumors\nEstimated primary completion: 6 February 2029. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/gsk5533524#upcoming-events\nRegis
 try record: https://clinicaltrials.gov/study/NCT07438782
URL:https://assetmemo.bio/drug/gsk5533524#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
